The patients were randomized into @ cohorts assigned to receive either @ mg ( @ mL of @ mg/mL ) subconjunctival bevacizumab ( treatment group ) or @ mL of balanced salt solution ( control group ) injected in an identical manner posterior to the bleb after the bleb needling .